50
Last reporting period 30 Jun, 2023
Updated —
Last price
—
Market cap $B
0.214
Exchange
XHKG - Hong Kong Exchange
0.046 B
Last period Cash and equivalents ,USD
134%
Cash and equivalents has increased in 5 years
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also Lansen Pharmaceutical
Company Analysis
503.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
503.HK financial analysis by Eyestock methodology
Valuation
503.HK valuation using historical relative method
Statements
503.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
503.HK dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
Lansen Pharmaceutical`s Cash and equivalents for the period ended 2023-06-30 are 0.046 B USD
